Clinical Trial to Test Antibody Use With Evrysdi & Thanksgiving Challenges

SMA News Today’s multimedia associate, Price Wooldridge, discusses how Roche and Genentech will initiate a Phase 2/3 clinical trial to evaluate the safety and efficacy of GYM329 in combination with Evrysdi in children with SMA.

Also, after thinking this Thanksgiving would resemble some normalcy, Covid throws a wrench into DeAnn’s family plans. She explains why their plans have changed and her feelings regarding it.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/